Bioventus expects 2026 revenue of $590M-$595M while reaffirming adjusted EPS of $0.75-$0.79

The Quick Take
Read the full report from the original publisher.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents.
Related
Markets
Ibotta projects at least mid-single-digit 2027 revenue growth as it guides Q4 revenue to $94M-$98M
Markets
After banking a +495% gain: A new list of AI picks for November is NOW LIVE
Markets
Europe stocks set to fall as US-Iran tensions fuel oil rebound
Local
Who Replaces CLARITY Champion Cynthia Lummis: Trump Backs Hageman
Wyoming voters pick a successor to Sen. Cynthia Lummis today, and Trump-backed Rep. Harriet Hageman is favored to inherit the seat of Washington’s loudest…
